🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the service has taken down problematic material and prohibited related keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.

Within minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.

Product Details and Costs

Within these groups, messages display black plastic parcels with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.